• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于推导群体药代动力学研究采样时间和窗口的序贯蒙特卡罗方法。

A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.

机构信息

Mathematical Sciences, Queensland University of Technology, Brisbane, QLD, 4001, Australia.

出版信息

J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):519-26. doi: 10.1007/s10928-012-9265-1. Epub 2012 Jul 31.

DOI:10.1007/s10928-012-9265-1
PMID:22847735
Abstract

Here we present a sequential Monte Carlo approach that can be used to find optimal designs. Our focus is on the design of population pharmacokinetic studies where the derivation of sampling windows is required, along with the optimal sampling schedule. The search is conducted via a particle filter which traverses a sequence of target distributions artificially constructed via an annealed utility. The algorithm derives a catalog of highly efficient designs which, not only contain the optimal, but can also be used to derive sampling windows. We demonstrate our approach by designing a hypothetical population pharmacokinetic study, and compare our results with those obtained via a simulation method from the literature.

摘要

在这里,我们提出了一种序贯蒙特卡罗方法,可用于寻找最佳设计。我们的重点是设计群体药代动力学研究,其中需要推导采样窗口以及最佳采样计划。搜索是通过粒子滤波器进行的,该滤波器通过通过退火效用人工构建的一系列目标分布进行遍历。该算法生成了一个高效设计目录,不仅包含最优设计,还可以用于推导采样窗口。我们通过设计一个假设的群体药代动力学研究来演示我们的方法,并将我们的结果与文献中模拟方法获得的结果进行比较。

相似文献

1
A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.一种用于推导群体药代动力学研究采样时间和窗口的序贯蒙特卡罗方法。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):519-26. doi: 10.1007/s10928-012-9265-1. Epub 2012 Jul 31.
2
Optimisation of sampling windows design for population pharmacokinetic experiments.
J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):465-82. doi: 10.1007/s10928-008-9097-1. Epub 2008 Sep 9.
3
Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.在序贯采样设计中进行药代动力学参数的非隔室估计。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):479-94. doi: 10.1007/s10928-009-9133-9. Epub 2009 Oct 22.
4
Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.哌拉西林/他唑巴坦在新生儿和小婴儿群体药代动力学研究中的目标达成分析及最优抽样设计
Eur J Clin Pharmacol. 2016 Dec;72(12):1479-1488. doi: 10.1007/s00228-016-2131-0. Epub 2016 Sep 19.
5
Optimal sampling times for pharmacokinetic experiments.药代动力学实验的最佳采样时间。
J Pharmacokinet Biopharm. 1981 Dec;9(6):739-56. doi: 10.1007/BF01070904.
6
A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.一种用于确定非线性混合效应模型采样窗口的通用方法及其在群体药代动力学研究中的应用。
Pharm Stat. 2012 Jul-Aug;11(4):325-33. doi: 10.1002/pst.1509. Epub 2012 Mar 12.
7
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trial.采用群体方法进行参数估计的最佳采血时间窗:一项II期临床试验的设计
J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):737-56. doi: 10.1007/s10928-005-0014-6.
8
Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia.为接受氯胺酮进行短期程序性镇静和镇痛的儿童制定最佳采样时间表。
Paediatr Anaesth. 2015 Feb;25(2):211-6. doi: 10.1111/pan.12521. Epub 2014 Sep 12.
9
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.使用 SIMCYP(®) 模拟作为先验信息确定药物及其代谢物的最佳采样时间。
Clin Pharmacokinet. 2013 Jan;52(1):43-57. doi: 10.1007/s40262-012-0022-9.
10
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.一种为群体药代动力学实验获取最佳采样窗口的有效方法。
J Biopharm Stat. 2009;19(1):174-89. doi: 10.1080/10543400802536131.

引用本文的文献

1
Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients.用于因药物依从性差而导致的儿童结节性硬化症患者的西罗莫司延迟或漏服剂量的补救剂量建议。
Curr Pharm Des. 2024;30(11):877-886. doi: 10.2174/0113816128299479240213151714.

本文引用的文献

1
A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.一种用于确定非线性混合效应模型采样窗口的通用方法及其在群体药代动力学研究中的应用。
Pharm Stat. 2012 Jul-Aug;11(4):325-33. doi: 10.1002/pst.1509. Epub 2012 Mar 12.
2
Adaptive design optimization: a mutual information-based approach to model discrimination in cognitive science.自适应设计优化:基于互信息的认知科学模型判别方法。
Neural Comput. 2010 Apr;22(4):887-905. doi: 10.1162/neco.2009.02-09-959.
3
Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations.
考虑一阶条件(FO)和条件期望一阶估计(FOCE)的药代动力学-药效学模型的同步与序贯最优设计
J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):101-23. doi: 10.1007/s10928-009-9113-0. Epub 2009 Feb 18.
4
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.一种为群体药代动力学实验获取最佳采样窗口的有效方法。
J Biopharm Stat. 2009;19(1):174-89. doi: 10.1080/10543400802536131.
5
Optimisation of sampling windows design for population pharmacokinetic experiments.
J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):465-82. doi: 10.1007/s10928-008-9097-1. Epub 2008 Sep 9.
6
Evaluation of uncertainty parameters estimated by different population PK software and methods.不同群体药代动力学软件和方法所估计的不确定性参数评估。
J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):289-311. doi: 10.1007/s10928-006-9046-9. Epub 2007 Jan 10.
7
Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.群体药代动力学实验中参数估计的最佳采血时间窗。
Stat Med. 2006 Dec 15;25(23):4004-19. doi: 10.1002/sim.2512.
8
Prospective evaluation of a D-optimal designed population pharmacokinetic study.一项D最优设计的群体药代动力学研究的前瞻性评估。
J Pharmacokinet Pharmacodyn. 2003 Apr;30(2):145-61. doi: 10.1023/a:1024467714170.
9
Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.非线性混合效应模型中Fisher信息矩阵在群体药代动力学评估方面的进一步发展。
J Biopharm Stat. 2003 May;13(2):209-27. doi: 10.1081/BIP-120019267.